Klogene Therapeutics, Inc.

About:

Prevention and treatment of age related diseases

Description:

Klogene is developing therapeutics for prevention and treatment of age related diseases based on increasing the level of the naturally occurring Klotho protein in the human body

Total Funding Amount:

$1.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2015-01-01

Contact Email:

mabraham(AT)klogene.com

Founders:

Carmela Abraham, Kevin Hodgetts, Menachem Abraham

Number of Employees:

11-50

Last Funding Date:

2018-07-01

IPO Status:

Private

Industries: